SNGX News and Press, Soligenix Inc.

2024-07-18 10:20:00 ET July 18, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compa...

NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView is pleased to announce an exclusive Q&A session with Dr. Ellen Kim, discussing the promising interim results of Soligenix's ( Nasdaq:SNGX ) HyBryte™ from the ongoing investigator-initiated study (IIS). HyBryte&#...

2024-07-10 07:23:10 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips These pre-market stock movers are worth checking out on Wednesday as we break down all of the biggest news this morning! Moving stocks are new contracts and agreements, ongoing rallies, ret...

A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 2.5% to $131.38 on volume of 280,159,738 shares Maxeon Solar Technologies Ltd. (MAXN) fell 8.1% to $0.248 on volume of 217,585,873 shares Tesla Inc. (TSLA) rose 3.7% to $262.33 on volume of 159,323,492 s...

Soligenix, Inc. (NASDAQ: SNGX) is one today's most active stocks by volume. So far today, approximately 99.97M shares of Soligenix, Inc. have been exchanged, as compared to an average 30-day volume of 148.21k shares. Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developin...

2024-07-09 10:48:10 ET More on Soligenix Soligenix stock dips on pricing $4.75 million securities offering Seeking Alpha’s Quant Rating on Soligenix Historical earnings data for Soligenix Financial information for Soligenix Read the full arti...

A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) fell 9.3% to $0.2448 on volume of 58,139,351 shares NVIDIA Corporation (NVDA) rose 2.9% to $131.9 on volume of 38,975,630 shares Soligenix Inc. (SNGX) rose 189.2% to $5.784 on volume of 36,915,609...

Expanded HyBryte™ Treatment Demonstrating Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma PR Newswire Study Supported by $2.6 Million FDA Orphan Products Development Grant PRINCETON, N.J. , July 9, 2024 /PRNewswire/ -- Soligenix, Inc...

Soligenix Announces Positive Clinical Results from a Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma PR Newswire HyBryte™ demonstrates more rapid and robust treatment response compared to Valchlor &#x...

A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference PR Newswire Advanced subunit vaccine technology, including SuVax™ and MarVax™, to be discussed alongside mRNA and viral vectored vaccine approaches PRINCETON, ...